QNCX

Conviction 93HealthcareScan · Mon, Aug 10, 2026

QNCX$30.75+1.82%

ResistanceSupportVol 14

Vol MA14 39.81K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Quince Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.quincetx.com ↗

Price30.75

Change+1.82%

Gap-1.72%

Rel volume1.63×

Avg volume41.08K

Avg $ vol925.9K

SMA 2022.25

SMA 5012.44

SMA 2004.29

Price vs 50+147.25%

Price vs 200+616.79%

MA stackbullish

50/200 cross—

Supertrendup · 24.49

RSI (14)92

MACD hist0.57

MACD crossbull · 5d

Stoch %K / %D97 / 96

ADX (14)68

+DI / −DI46 / 4

RSI divergenceBearish

MACD divergenceBearish

ATR %+6.04%

ADR %8.91%

52w high30.75

52w low0.0800

From 52w high+0.00%

Above 52w low+38337.50%

New 52w highYes

SqueezeOff

Bollinger width81.90%

%B0.97

Donchian pos97.32%

Donchian high31.15

Donchian low16.23

AVWAP (52w high)30.53

vs AVWAP high+0.73%

AVWAP (52w low)0.2294

vs AVWAP low+13302.68%

OBV trendUp

Chaikin MF (20)0.31

Today vs 20d1.63×

Avg vol (14d)39.81K

Avg vol (20d)41.08K

Avg $ vol (20d)925.9K

Market cap501.25M

RS 3m (vs SPY)+2217.38%

RS 6m (vs SPY)+20556.66%

RS line new highYes

Trend template8/8

Technical rank99.1

1 week+23.17%

1 month+75.31%

3 months+2302.34%

6 months+22006.40%

1 year+1741.32%

YTD+925.00%

P/E-5.97

P/B31.98

P/S—

P/FCF-12.00

EPS-1.68

Div yield—

ROE-535.85%

ROA-315.44%

Debt/Eq0.00

Current2.92

EV/EBITDA-8.34

Gross margin—

Net margin—

Rev growth—

EPS growth-47.78%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value483.08M

Revenue—

Net income35.91M

Gross profit—

Free cash flow-41.78M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out16.3M

Employees38

ListedThu, May 9, 2019

Free float46.73M

Float %83.9%

Short interest50.57K

Days to cover1.2d

Short volume48.7%

Squeeze score21 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction93 / 100

Pattern quality—

Tech rank99.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance19.99

Support0.8842

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 14
1 scan
→
Breaking out now
Jul 29
1 scan

Congress activity

Disclosed STOCK Act trades in QNCX

All disclosures →

No recent disclosed trades by Congress in QNCX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QNCX

No recent insider (Form 4) filings in QNCX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in QNCX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.